Xavier Tréton

4.7k total citations
105 papers, 2.5k citations indexed

About

Xavier Tréton is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Xavier Tréton has authored 105 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Genetics, 44 papers in Epidemiology and 37 papers in Surgery. Recurrent topics in Xavier Tréton's work include Inflammatory Bowel Disease (58 papers), Microscopic Colitis (30 papers) and Diverticular Disease and Complications (17 papers). Xavier Tréton is often cited by papers focused on Inflammatory Bowel Disease (58 papers), Microscopic Colitis (30 papers) and Diverticular Disease and Complications (17 papers). Xavier Tréton collaborates with scholars based in France, United States and Switzerland. Xavier Tréton's co-authors include Yoram Bouhnik, Yves Panís, Matthieu Allez, Philippe Seksik, Éric Ogier‐Denis, Philippe Marteau, Marc Lémann, Fanny Daniel, Dominique Cazals‐Hatem and Jean–Claude Soulé and has published in prestigious journals such as The Lancet, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Xavier Tréton

98 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xavier Tréton France 27 1.3k 993 801 591 469 105 2.5k
Joel Pekow United States 35 1.4k 1.1× 1.3k 1.3× 760 0.9× 913 1.5× 419 0.9× 116 3.2k
Pál Miheller Hungary 26 1.0k 0.8× 823 0.8× 456 0.6× 363 0.6× 442 0.9× 116 2.0k
Brigid S. Boland United States 31 1.7k 1.3× 1.2k 1.2× 803 1.0× 645 1.1× 1.1k 2.3× 99 3.4k
Bram Verstockt Belgium 33 2.1k 1.6× 1.3k 1.3× 765 1.0× 628 1.1× 919 2.0× 229 3.1k
Zhirong Zeng China 23 830 0.6× 557 0.6× 580 0.7× 419 0.7× 456 1.0× 76 1.8k
Murat Törüner Türkiye 20 1.3k 1.0× 1.6k 1.6× 696 0.9× 311 0.5× 433 0.9× 63 2.9k
Frank Hoentjen Netherlands 27 1.6k 1.2× 1.1k 1.1× 628 0.8× 417 0.7× 752 1.6× 165 2.7k
Lior H. Katz Israel 23 583 0.4× 768 0.8× 524 0.7× 435 0.7× 289 0.6× 92 2.1k
Fabrizio Bossa Italy 24 1.0k 0.8× 683 0.7× 605 0.8× 207 0.4× 369 0.8× 94 1.8k
Jon Florholmen Norway 27 886 0.7× 551 0.6× 524 0.7× 378 0.6× 771 1.6× 60 2.0k

Countries citing papers authored by Xavier Tréton

Since Specialization
Citations

This map shows the geographic impact of Xavier Tréton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Tréton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Tréton more than expected).

Fields of papers citing papers by Xavier Tréton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Tréton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Tréton. The network helps show where Xavier Tréton may publish in the future.

Co-authorship network of co-authors of Xavier Tréton

This figure shows the co-authorship network connecting the top 25 collaborators of Xavier Tréton. A scholar is included among the top collaborators of Xavier Tréton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier Tréton. Xavier Tréton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kirchgesner, Julien, Mathieu Uzzan, Carmen Stéfanescu, et al.. (2024). Early ileal resection in Crohn's disease is not associated with severe long‐term outcomes: The ERIC study. Alimentary Pharmacology & Therapeutics. 60(10). 1388–1397.
2.
Farge, Dominique, G. Pugnet, Matthieu Allez, et al.. (2024). French protocol for the diagnosis and management of hematopoietic stem cell transplantation in autoimmune diseases. La Revue de Médecine Interne. 45(2). 79–99. 2 indexed citations
3.
4.
Buisson, Anthony, Harry Sokol, Nassim Hammoudi, et al.. (2022). Role of adherent and invasive Escherichia coli in Crohn’s disease: lessons from the postoperative recurrence model. Gut. 72(1). 39–48. 33 indexed citations
5.
Tréton, Xavier, et al.. (2022). Intra‐abdominal abscesses in CD – When to treat with biologics?. United European Gastroenterology Journal. 10(10). 1085–1090. 4 indexed citations
6.
Buisson, Anthony, Maria Nachury, Romain Altwegg, et al.. (2022). Real‐world comparison of effectiveness between tofacitinib and vedolizumab in patients with ulcerative colitis exposed to at least one anti‐TNF agent. Alimentary Pharmacology & Therapeutics. 57(6). 676–688. 15 indexed citations
7.
Posseme, Céline, Julien Edeline, Cédric Coulouarn, et al.. (2022). Anterior gradient proteins in gastrointestinal cancers: from cell biology to pathophysiology. Oncogene. 41(42). 4673–4685. 9 indexed citations
8.
Guedj, Kévin, Mathieu Uzzan, Catherine Trichet, et al.. (2021). I-FABP is decreased in COVID-19 patients, independently of the prognosis. PLoS ONE. 16(4). e0249799–e0249799. 12 indexed citations
9.
10.
Uzzan, Mathieu, Olivier Corcos, Jérôme C. Martin, Xavier Tréton, & Yoram Bouhnik. (2020). Why is SARS-CoV-2 infection more severe in obese men? The gut lymphatics – Lung axis hypothesis. Medical Hypotheses. 144. 110023–110023. 26 indexed citations
11.
Auzolle, Claire, Stéphane Nancey, My‐Linh Tran‐Minh, et al.. (2018). Male gender, active smoking and previous intestinal resection are risk factors for post‐operative endoscopic recurrence in Crohn's disease: results from a prospective cohort study. Alimentary Pharmacology & Therapeutics. 48(9). 924–932. 63 indexed citations
12.
Fernandez, Neïké, Valérie Gratio, Pascal Nicole, et al.. (2018). Ectopic expression of OX1R in ulcerative colitis mediates anti-inflammatory effect of orexin-A. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(11). 3618–3628. 28 indexed citations
13.
Ladeiro, Yannick, Ian Morilla, Yoram Bouhnik, et al.. (2016). Integrative Network-based Analysis of Colonic Detoxification Gene Expression in Ulcerative Colitis According to Smoking Status. Journal of Crohn s and Colitis. 11(4). jjw179–jjw179. 8 indexed citations
14.
Uzzan, Mathieu, Jean‐Frédéric Colombel, Andrea Cerutti, Xavier Tréton, & Saurabh Mehandru. (2016). B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases. Digestive Diseases and Sciences. 61(12). 3407–3424. 32 indexed citations
15.
Maggiori, Léon, et al.. (2014). Laparoscopic Approach for Inflammatory Bowel Disease Is a Real Alternative to Open Surgery. Annals of Surgery. 260(2). 305–310. 20 indexed citations
16.
Corcos, Olivier, Dominique Cazals‐Hatem, François Durand, et al.. (2013). Intestinal failure after bariatric surgery. The Lancet. 382(9893). 742–742. 8 indexed citations
17.
Amiot, Aurélien, Matthieu Allez, Xavier Tréton, et al.. (2011). High frequency of fatal haemophagocytic lymphohistiocytosis syndrome in enteropathy-associated T cell lymphoma. Digestive and Liver Disease. 44(4). 343–349. 10 indexed citations
18.
Zappa, Magaly, Carmen Stefănescu, Dominique Cazals‐Hatem, et al.. (2010). Which magnetic resonance imaging findings accurately evaluate inflammation in small bowel Crohnʼs disease? A retrospective comparison with surgical pathologic analysis. Inflammatory Bowel Diseases. 17(4). 984–993. 181 indexed citations
19.
Sokol, Harry, Anne Lavergne‐Slove, Yves Panís, et al.. (2009). Plexitis as a predictive factor of early postoperative clinical recurrence in Crohn’s disease. Gut. 58(9). 1218–1225. 84 indexed citations
20.
Allez, Matthieu, Séverine Vermeire, Pierre Michetti, et al.. (2009). The efficacy and safety of a third anti‐TNF monoclonal antibody in Crohn’s disease after failure of two other anti‐TNF antibodies. Alimentary Pharmacology & Therapeutics. 31(1). 92–101. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joel Pekow Breakdown of academic impact, for papers by Pál Miheller Breakdown of academic impact, for papers by Brigid S. Boland Breakdown of academic impact, for papers by Bram Verstockt Breakdown of academic impact, for papers by Zhirong Zeng Breakdown of academic impact, for papers by Murat Törüner Breakdown of academic impact, for papers by Frank Hoentjen Breakdown of academic impact, for papers by Lior H. Katz Breakdown of academic impact, for papers by Fabrizio Bossa Breakdown of academic impact, for papers by Jon Florholmen
Rankless by CCL
2026